Collegium Pharmaceutical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Collegium Pharmaceutical, Inc. (COLL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 717.30 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-25.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-02-25
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-12-31 was 50.25K shares.
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 148.35K shares, a 71.26% increase year-over-year.
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 196.76K shares, a 22.15% decline year-over-year.
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-03-31 was 700.55K shares, a 11.65% decline year-over-year.
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 717.30K shares, a 34.55% decline from fiscal 2019.
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.10M shares.
- Collegium Pharmaceutical, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 1.16M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | 717.30K shares 10-K · filed 2021-02-25 | ||||
| 2019-12-31 | 50.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 198.60K shares derived: sum of 2 quarters · filed 2020-02-27 | 395.36K shares derived: sum of 3 quarters · filed 2020-02-27 | 1.10M shares 10-K · filed 2020-02-27 | |
| 2019-09-30 | 148.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 345.11K shares derived: sum of 2 quarters · filed 2019-11-06 | 1.05M shares 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | 196.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 897.31K shares 10-Q · filed 2019-08-07 | |||
| 2019-03-31 | 700.55K shares 10-Q · filed 2019-05-08 | ||||
| 2018-09-30 | 86.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 339.36K shares derived: sum of 2 quarters · filed 2018-11-08 | 1.13M shares 10-Q · filed 2018-11-08 | 1.03M shares derived: sum of 4 quarters · filed 2019-02-27 | |
| 2018-06-30 | 252.74K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 1.05M shares 10-Q · filed 2018-08-08 | 943.57K shares derived: sum of 3 quarters · filed 2019-02-27 | 978.51K shares derived: sum of 4 quarters · filed 2019-02-27 | |
| 2018-03-31 | 792.92K shares 10-Q · filed 2018-05-09 | 690.83K shares derived: sum of 2 quarters · filed 2019-02-27 | 725.77K shares derived: sum of 3 quarters · filed 2019-02-27 | 1.32M shares derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-12-31 | -102.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -67.15K shares derived: sum of 2 quarters · filed 2019-02-27 | 526.38K shares derived: sum of 3 quarters · filed 2019-02-27 | 1.16M shares 10-K · filed 2019-02-27 | 1.38M shares 10-K · filed 2018-03-07 |
| 2017-09-30 | 34.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 628.47K shares derived: sum of 2 quarters · filed 2017-11-08 | 1.26M shares 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | 593.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 1.23M shares 10-Q · filed 2017-08-09 | |||
| 2017-03-31 | 632.90K shares 10-Q · filed 2017-05-10 | ||||
| 2016-09-30 | 45.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 448.60K shares derived: sum of 2 quarters · filed 2016-11-10 | 970.48K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 403.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | 924.98K shares 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | 521.88K shares 10-Q · filed 2016-05-11 | ||||
| 2015-09-30 | 1.20M shares 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |